Medical News

RSS

Unisys' Mexican subsidiary wins contract to develop biometric citizen identification solution

Unisys today announced that its Mexican subsidiary has been awarded a contract by the Secretaria de Gobernacion/Registro Nacional de Poblacion (Mexican Ministry of Internal Affairs/National Citizen Registry) to create and manage an advanced citizen identification solution using biometric technologies.

4 Feb 2010

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010.

4 Feb 2010

Waiting for birth as effective as inducing labor for intrauterine growth restriction

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting -, in Chicago, researchers will unveil findings that show that waiting for birth is as effective as inducing labor in cases of intrauterine growth restriction (IUGR).

4 Feb 2010

Health Discovery receives final patent infringement payment from Vermillion

Health Discovery Corporation announced today that the Company has received the final payment that was due under the agreement that settled the Company’s patent infringement lawsuit against Vermillion, formerly known as Ciphergen Biosystems, Inc.

4 Feb 2010

Researchers develop simple urine test to predict and diagnose preeclampsia

Researchers at Yale School of Medicine have developed a simple urine test to rapidly predict and diagnose preeclampsia, a common, but serious hypertensive complication of pregnancy.

4 Feb 2010

EUCODIS Bioscience to utilize EUR 2M capital injection for adding enzyme families and development of international markets

EUCODIS Bioscience, a company providing customized enzymes to the pharmaceutical, chemical, and other industries, announced today that it has received a cash injection of EUR 2 million from existing shareholders.

4 Feb 2010

Study on the role of MCP-1 in obese patients with pancreatic cancer

The levels of an inflammatory chemokine were significantly elevated in patients with pancreatic cancer who were extremely obese, according to research conducted by scientists at the Jefferson Pancreatic, Biliary and Related Cancers Center. They presented their data at the 5th Annual Academic Surgical Congress, held in San Antonio.

4 Feb 2010

Blood cytokine levels may help in predicting arthritic rheumatism

Levels of inflammatory proteins, so-called cytokines, are elevated in the blood even before the onset of arthritic rheumatism. This means that such blood samples could be used to predict the development of the disease and thereby make it possible to prevent the pathological process, according to an article by Umeå researcher Solbritt Rantapää-Dahlqvist and her associates in the journal Arthritis and Rheumatism.

4 Feb 2010

Researchers uncover new mechanism to protect individuals from serious complications of obesity

Although obesity is a risk factor for diabetes and coronary heart disease worldwide, only some obese individuals go on to develop these metabolic complications, while others are relatively protected. Defining these protective factors could help scientists prevent disease in the wider population.

4 Feb 2010

CRN issues statement on "The Dietary Supplement Safety Act of 2010"

The responsible dietary supplement industry represents the health and wellness interests of more than 150 million Americans who use dietary supplements each year. The number one priority for CRN and our members is to ensure that our consumers have access to safe, beneficial products that they can incorporate into their daily wellness regimens.

4 Feb 2010

1st Annual Biliary Tract-Gallbladder Cancer Research Symposium to be held at ASCO in Alexandria

CanLiv: The Hepatobiliary Cancers Foundation in partnership with The Cholangiocarcinoma Foundation will host the 1st Annual Biliary Tract-Gallbladder Cancer Research Symposium on Friday, May 7, 2010 at the American Society of Clinical Oncologists (ASCO) headquarters in Alexandria, Virginia.

4 Feb 2010

New African Union chair's focus to include food security; First Ladies discuss HIV/AIDS

The African Union (AU) Summit concluded in Addis Ababa, Ethiopia, on Tuesday with newly elected AU chairman Bingu Wa Mutharika, of Malawi, encouraging African leaders to make agriculture and food security a top priority, Angola Press reports (2/2).

4 Feb 2010

PLX cell therapy may be an effective treatment for ischemic stroke disorder

Pluristem Therapeutics Inc. today announced that the results of a pre-clinical study in an animal model of ischemic stroke demonstrated that its PLacental eXpanded (PLX) cell therapy may be an effective treatment for this disorder.

4 Feb 2010

USPTO issues three patents to Rosetta Genomics

Rosetta Genomics today announced that the United States Patent and Trademark Office (USPTO) has issued three patents to the company covering the composition of matter of human microRNAs.

4 Feb 2010

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

Medical College of Georgia researchers are seeking to refine cancer treatment with an anti-inflammatory plant derivative long used in Chinese medicine.

4 Feb 2010

Ipsen launches Decapeptyl LP 22.5 mg in France

Ipsen, an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22.5 mg 6-month sustained-release formulation for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.

4 Feb 2010

Photocontrolled molecular switch regulates paralysis in animals

In an advance with overtones of Star Trek phasers and other sci-fi ray guns, scientists in Canada are reporting development of an internal on-off "switch" that paralyzes animals when exposed to a beam of ultraviolet light. The animals stay paralyzed even when the light is turned off. When exposed to ordinary light, the animals become unparalyzed and wake up.

4 Feb 2010

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

Advanced Cancer Therapeutics (ACT), a for-profit private company dedicated to bringing new anti-cancer therapies to market, today announced that it has signed an agreement to leverage the computational chemistry expertise of Dr. John Trent, Associate Professor, Department of Medicine at the University of Louisville’s James Graham Brown Cancer Center (Brown Cancer Center), to accelerate the identification of new clinical candidates for the prevention and treatment of cancer.

4 Feb 2010

GTRI researchers design arthritis simulation gloves to meet the needs of consumers with functional limitations

As the U.S. population ages, manufacturers of consumer goods are realizing that many customers may not be as nimble-fingered or sharp-sighted as they once were.

4 Feb 2010

Shire's clinical study results for treatment of Gaucher disease to be presented at LDN World Symposium

Shire plc, the global specialty biopharmaceutical company, today announced that data from one of three Phase III clinical trials for velaglucerase alfa, the company's enzyme replacement therapy (ERT) in development for the treatment of Type 1 Gaucher disease, will be presented at the Lysosomal Disease Network (LDN) World Symposium, February 10-12, 2010 in Miami, Florida.

4 Feb 2010

Medical News

Unisys' Mexican subsidiary wins contract to develop biometric citizen identification solution

Finland commits 1.85M as initial funding for development of European biomedical research infrastructures

Waiting for birth as effective as inducing labor for intrauterine growth restriction

Health Discovery receives final patent infringement payment from Vermillion

Researchers develop simple urine test to predict and diagnose preeclampsia

EUCODIS Bioscience to utilize EUR 2M capital injection for adding enzyme families and development of international markets

Study on the role of MCP-1 in obese patients with pancreatic cancer

Blood cytokine levels may help in predicting arthritic rheumatism

Researchers uncover new mechanism to protect individuals from serious complications of obesity

CRN issues statement on "The Dietary Supplement Safety Act of 2010"

1st Annual Biliary Tract-Gallbladder Cancer Research Symposium to be held at ASCO in Alexandria

New African Union chair's focus to include food security; First Ladies discuss HIV/AIDS

PLX cell therapy may be an effective treatment for ischemic stroke disorder

USPTO issues three patents to Rosetta Genomics

Anti-inflammatory plant derivative could play a role in cancer treatment, say MCG researchers

Ipsen launches Decapeptyl LP 22.5 mg in France

Photocontrolled molecular switch regulates paralysis in animals

ACT and Brown Cancer Center scientist collaborate in discovery of new therapeutics for cancer

GTRI researchers design arthritis simulation gloves to meet the needs of consumers with functional limitations

Shire's clinical study results for treatment of Gaucher disease to be presented at LDN World Symposium

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News